NL8102362A - Farmaceutische antitumor-preparaat; werkwijze voor de bereiding daarvan. - Google Patents

Farmaceutische antitumor-preparaat; werkwijze voor de bereiding daarvan. Download PDF

Info

Publication number: NL8102362A
Authority: NL; Netherlands
Prior art keywords: lactic acid; amsa; preparation; water; solution
Prior art date: 1980-05-16

Application number

NL8102362A

Other languages

English (en)

Dutch (nl)

Original Assignee

Bristol Myers Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1980-05-16

Filing date

1981-05-13

Publication date

1981-12-16

1981-05-13 Application filed by Bristol Myers Co filed Critical Bristol Myers Co

1981-12-16 Publication of NL8102362A publication Critical patent/NL8102362A/nl

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Epidemiology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Dermatology (AREA)
Engineering & Computer Science (AREA)
Oil, Petroleum & Natural Gas (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

NL8102362A 1980-05-16 1981-05-13 Farmaceutische antitumor-preparaat; werkwijze voor de bereiding daarvan. NL8102362A (nl)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US14705680		1980-05-16
US06/147,056 US4360523A (en)	1980-05-16	1980-05-16	Pharmaceutical formulations of 4'-(9-acridinylamino)-methanesulfon-m-anisidide

Publications (1)

Publication Number	Publication Date
NL8102362A true NL8102362A (nl)	1981-12-16

Family

ID=22520148

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NL8102362A NL8102362A (nl)	1980-05-16	1981-05-13	Farmaceutische antitumor-preparaat; werkwijze voor de bereiding daarvan.

Country Status (21)

Country	Link
US (1)	US4360523A (fi)
JP (1)	JPS579716A (fi)
AT (1)	AT374682B (fi)
AU (1)	AU543726B2 (fi)
BE (1)	BE888832A (fi)
CA (1)	CA1160571A (fi)
CH (1)	CH647677A5 (fi)
DE (1)	DE3119510A1 (fi)
DK (1)	DK159376C (fi)
FI (1)	FI70793C (fi)
FR (1)	FR2482458A1 (fi)
GB (1)	GB2076288B (fi)
GR (1)	GR75658B (fi)
IE (1)	IE51285B1 (fi)
IT (1)	IT1170970B (fi)
LU (1)	LU83363A1 (fi)
NL (1)	NL8102362A (fi)
NZ (1)	NZ196985A (fi)
SE (1)	SE460457B (fi)
YU (1)	YU44831B (fi)
ZA (1)	ZA813188B (fi)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4575509A (en) *	1983-01-31	1986-03-11	Bristol-Myers Company	Water-soluble formulations of m-AMSA with pyroglutamic acid
US4626541A (en) *	1985-09-12	1986-12-02	Bristol-Myers Company	Water soluble salt composition of m-AMSA
DE3844518A1 (de) *	1988-03-23	1989-10-05	Karl Heinz Dr Med Thiel	Verwendung von aminochinolinen und aminopyridinen zur iontophoretischen behandlung maligner tumore
DE3819842C1 (fi) *	1988-03-23	1989-12-21	Karl Heinz Dr. 7100 Heilbronn De Thiel
CA2143515A1 (en) *	1994-03-22	1995-09-23	Prakash Parab	Method for enhancing the rate of skin permeation of lactic acid through use of the l-enantiomer
DE102004031538A1 (de) *	2004-06-29	2006-02-09	Baxter International Inc., Deerfield	Pharmazeutische Darreichungsform zur oralen Verabreichung eines schwerlöslichen Wirkstoffs, Verfahren zu deren Herstellung und Kit
WO2006002887A1 (en) *	2004-06-29	2006-01-12	Baxter International Inc.	Aqueous drink solution of indibulin (d-24851) and an organic acid
US20060110462A1 (en) *	2004-11-08	2006-05-25	Pavlos Papadopoulos	Nanoparticulate compositions of tubulin inhibitor compounds
JP2010511041A (ja) *	2006-11-28	2010-04-08	ジオファームオンコロジー，インコーポレイテッド	インジブリンを含むインドリル−３−グリオキシル酸誘導体の癌を処置するための単独またはさらなる薬剤との組み合わせでの使用
ES2992725T3 (en) *	2014-03-31	2024-12-17	Teymuras Kurzchalia	Glycolic acid and/or d-lactic acid for the treatment of neurodegenerative diseases

1980
- 1980-05-16 US US06/147,056 patent/US4360523A/en not_active Expired - Lifetime
1981
- 1981-04-27 CA CA000376348A patent/CA1160571A/en not_active Expired
- 1981-04-30 YU YU1123/81A patent/YU44831B/xx unknown
- 1981-05-01 NZ NZ196985A patent/NZ196985A/xx unknown
- 1981-05-06 GR GR64859A patent/GR75658B/el unknown
- 1981-05-08 AU AU70291/81A patent/AU543726B2/en not_active Ceased
- 1981-05-13 FR FR8109497A patent/FR2482458A1/fr active Granted
- 1981-05-13 ZA ZA00813188A patent/ZA813188B/xx unknown
- 1981-05-13 FI FI811474A patent/FI70793C/fi not_active IP Right Cessation
- 1981-05-13 NL NL8102362A patent/NL8102362A/nl not_active Application Discontinuation
- 1981-05-14 DK DK216681A patent/DK159376C/da active
- 1981-05-14 IT IT48467/81A patent/IT1170970B/it active
- 1981-05-15 CH CH3195/81A patent/CH647677A5/de not_active IP Right Cessation
- 1981-05-15 IE IE1092/81A patent/IE51285B1/en unknown
- 1981-05-15 LU LU83363A patent/LU83363A1/fr unknown
- 1981-05-15 SE SE8103071A patent/SE460457B/sv not_active IP Right Cessation
- 1981-05-15 JP JP7239381A patent/JPS579716A/ja active Granted
- 1981-05-15 GB GB8114947A patent/GB2076288B/en not_active Expired
- 1981-05-15 BE BE0/204812A patent/BE888832A/fr not_active IP Right Cessation
- 1981-05-15 DE DE19813119510 patent/DE3119510A1/de active Granted
- 1981-05-18 AT AT0221181A patent/AT374682B/de active

Also Published As

Publication number	Publication date
CA1160571A (en)	1984-01-17
GB2076288A (en)	1981-12-02
JPS579716A (en)	1982-01-19
FI811474L (fi)	1981-11-17
AT374682B (de)	1984-05-25
DK159376B (da)	1990-10-08
DK159376C (da)	1991-03-25
FI70793B (fi)	1986-07-18
SE8103071L (sv)	1981-11-17
FR2482458B1 (fi)	1984-12-14
FI70793C (fi)	1986-10-27
CH647677A5 (de)	1985-02-15
DE3119510C2 (fi)	1991-03-07
SE460457B (sv)	1989-10-16
GB2076288B (en)	1983-12-14
AU7029181A (en)	1981-11-19
YU44831B (en)	1991-04-30
DK216681A (da)	1981-11-17
IT8148467A0 (it)	1981-05-14
AU543726B2 (en)	1985-05-02
IE51285B1 (en)	1986-11-26
BE888832A (fr)	1981-11-16
DE3119510A1 (de)	1982-02-25
IE811092L (en)	1981-11-16
IT1170970B (it)	1987-06-03
NZ196985A (en)	1983-06-17
ATA221181A (de)	1983-10-15
ZA813188B (en)	1982-05-26
LU83363A1 (fr)	1982-01-20
FR2482458A1 (fr)	1981-11-20
YU112381A (en)	1985-03-20
JPH0136445B2 (fi)	1989-07-31
US4360523A (en)	1982-11-23
GR75658B (fi)	1984-08-02

Publication	Publication Date	Title
US20030109515A1 (en)	2003-06-12	Pharmaceutical formulation of a platinum derivative
CN102018714B (zh)	2014-01-08	制剂
NL8102362A (nl)	1981-12-16	Farmaceutische antitumor-preparaat; werkwijze voor de bereiding daarvan.
EP0261426B1 (en)	1992-11-04	Freeze-dried pharmaceutical compositions of phenylquinoline carboxylic acids
US4425348A (en)	1984-01-10	Antitumor compositions
JP2000509013A (ja)	2000-07-18	ウルソデオキシコール酸またはタウロウルソデオキシコール酸、強塩基、およびトロメタモールを含む注射可能な薬学的組成物
JPH0343251B2 (fi)	1991-07-01
EP1508332A1 (en)	2005-02-23	Medicinal composition
US4322424A (en)	1982-03-30	Crystalline glucoconate salt of m-AMSA and compositions containing same
JPH0366617A (ja)	1991-03-22	静脈内投与用フエニトインナトリウム製剤
NL8006440A (nl)	1981-07-01	Verbindingen en preparaten met anti-tumorwerking; werkwijze voor het bereiden daarvan.
KR20250070034A (ko)	2025-05-20	오렐라닌 제제
CA1159368A (en)	1983-12-27	Antitumor compositions
JP2022519343A (ja)	2022-03-23	ベンゾアゼピン化合物含有医薬組成物
HK1072002B (en)	2010-05-07	Platinum derivative pharmaceutical formulations

Legal Events

Date	Code	Title	Description
1985-01-01	A85	Still pending on 85-01-01
1988-07-01	BA	A request for search or an international-type search has been filed
1988-07-01	BB	A search report has been drawn up
1988-12-01	BC	A request for examination has been filed
1990-05-16	DNT	Communications of changes of names of applicants whose applications have been laid open to public inspection	Free format text: BRISTOL-MYERS SQUIBB COMPANY
1992-01-02	BV	The patent application has lapsed